ATL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.720400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.335800E-01
Normal-vs-Stage2
6.834400E-01
Normal-vs-Stage3
1.148320E-02
Normal-vs-Stage4
9.040000E-01
Stage1-vs-Stage2
6.979200E-01
Stage1-vs-Stage3
1.264040E-01
Stage1-vs-Stage4
5.253600E-01
Stage2-vs-Stage3
6.738200E-02
Stage2-vs-Stage4
7.259200E-01
Stage3-vs-Stage4
5.331600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.872600E-01
Normal-vs-AfricanAmerican
7.589000E-01
Normal-vs-Asian
5.990200E-01
Caucasian-vs-AfricanAmerican
7.487200E-01
Caucasian-vs-Asian
9.042400E-01
AfricanAmerican-vs-Asian
8.348000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.306800E-01
Normal-vs-Female
7.783700E-02
Male-vs-Female
7.707600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.735800E-01
Normal-vs-Age(41-60Yrs)
9.163200E-01
Normal-vs-Age(61-80Yrs)
3.418200E-01
Normal-vs-Age(81-100Yrs)
3.758000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.814200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.462800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.036400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.583500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.381600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.447200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.486600E-01
Normal-vs-Daily Drinker
4.104800E-01
Normal-vs-Weekly Drinker
1.750760E-01
Normal-vs-Occasional Drinker
9.558200E-01
Normal-vs-Social Drinker
7.806400E-01
Non Drinker-vs-Daily Drinker
4.599400E-01
Non Drinker-vs-Weekly Drinker
2.668000E-01
Non Drinker-vs-Occasional Drinker
4.830600E-01
Non Drinker-vs-Social Drinker
7.894000E-01
Daily Drinker-vs-Weekly Drinker
7.605600E-01
Daily Drinker-vs-Occasional Drinker
1.370400E-01
Daily Drinker-vs-Social Drinker
2.809800E-01
Weekly Drinker-vs-Occasional Drinker
8.746200E-02
Weekly Drinker-vs-Social Drinker
1.430430E-01
Occasional Drinker-vs-Social Drinker
6.519200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.409800E-02
Normal-vs-Grade 2
1.546180E-02
Normal-vs-Grade 3
4.294200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.354400E-02
Grade 1-vs-Grade 3
1.411770E-02
Grade 1-vs-Grade 4
8.409800E-02
Grade 2-vs-Grade 3
2.270200E-01
Grade 2-vs-Grade 4
1.546180E-02
Grade 3-vs-Grade 4
4.294200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.015400E-01
Normal-vs-NonDiabetic
4.314000E-02
Diabetic-vs-NonDiabetic
3.736000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.792400E-01
Normal-vs-NoPancreatitis
5.166800E-01
Pancreatitis-vs-NoPancreatitis
2.301800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.044800E-01
Normal-vs-N1
6.900200E-01
N0-vs-N1
1.168240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.114800E-01
Normal-vs-TP53-NonMutant
6.311800E-01
TP53-Mutant-vs-TP53-NonMutant
4.706400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
